Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -11.493% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. CN1CCN(C(=O)Cn2c(=O)oc3cc(S(=O)(=O)NCc4ccccc4)ccc32)CC1
b. CCCCn1c(N)c(N(CC(C)C)C(=O)CSCc2c(C)noc2C)c(=O)[nH]c1=O
c. CCCCOc1ccc(C(=O)NCCc2cccs2)cc1
d. Cc1cc(Cl)ccc1OCC(=O)Nc1ccccc1CO
e. CCSc1nnc(NC(=O)CSc2nc3c(c(=O)n2C)SC(C)C3)s1
Answer: e. CCSc1nnc(NC(=O)CSc2nc3c(c(=O)n2C)SC(C)C3)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCSc1nnc(NC(=O)CSc2nc3c(c(=O)n2C)SC(C)C3)s1
CCSc1nnc(NC(=O)CSc2nc3c(c(=O)n2C)SC(C)C3)s1
2-[(3,6-dimethyl-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)sulfanyl]-N-(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl)acetamide